These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16836502

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of scabies with 5% permethrin cream: results of a German multicenter study.
    Hamm H, Beiteke U, Höger PH, Seitz CS, Thaci D, Sunderkötter C.
    J Dtsch Dermatol Ges; 2006 May; 4(5):407-13. PubMed ID: 16686608
    [Abstract] [Full Text] [Related]

  • 23. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries.
    Brooks PA, Grace RF.
    J Paediatr Child Health; 2002 Aug; 38(4):401-4. PubMed ID: 12174005
    [Abstract] [Full Text] [Related]

  • 24. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J.
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [Abstract] [Full Text] [Related]

  • 25. Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: epidemiology; assessment of clinical, haematological, cell-mediated humoral immune responses and pathology.
    Dimri U, Sharma MC.
    J Vet Med A Physiol Pathol Clin Med; 2004 Mar; 51(2):71-8. PubMed ID: 15153076
    [Abstract] [Full Text] [Related]

  • 26. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial.
    Meyersburg D, Hoellwerth M, Brandlmaier M, Handisurya A, Kaiser A, Prodinger C, Bauer JW.
    Br J Dermatol; 2024 Mar 15; 190(4):486-491. PubMed ID: 38112640
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparative study between 10 per cent sulfur ointment and 0.3 per cent gamma benzene hexachloride gel in the treatment of scabies in children.
    Singalavanija S, Limpongsanurak W, Soponsakunkul S.
    J Med Assoc Thai; 2003 Aug 15; 86 Suppl 3():S531-6. PubMed ID: 14700144
    [Abstract] [Full Text] [Related]

  • 31. [Pyrethrin and pyrethroid (permethrin) in the treatment of scabies and pediculosis].
    Haustein UF.
    Hautarzt; 1991 Jan 15; 42(1):9-15. PubMed ID: 2010292
    [Abstract] [Full Text] [Related]

  • 32. [Crusted scabies (Norwegian scabies) a case report].
    Fernández-Tamayo N, Flores-Villa R, Blanco-Aguilar J, Dueñas-Arau Mde L, Peña-Flores Mdel P, Rubio-Calva C, Santos-Marcial E.
    Gac Med Mex; 2006 Jan 15; 142(6):507-10. PubMed ID: 17201114
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial.
    Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M.
    Curr Med Res Opin; 2005 Dec 15; 21(12):1949-53. PubMed ID: 16368045
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid.
    Quadri G, Cavallero W, Milani M.
    J Cosmet Dermatol; 2005 Jan 15; 4(1):23-6. PubMed ID: 17134417
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.